Streamlining the path from detection to referral for Alzheimer's: Insights from health system executives
As the U.S. population ages, health systems are readying to care for more patients with Alzheimer's disease. Early detection and quick time to treatment are critical to improve patients' quality of life, but systems are up against key barriers in being able to do so at scale.
Health system executives participated in a roundtable sponsored by Eli Lilly and Company at Becker's 14th Annual Meeting in April to discuss how they're positioning themselves to handle the complexities of Alzheimer's care. This report features key takeaways from the session.
Key learnings points:
Health system executives participated in a roundtable sponsored by Eli Lilly and Company at Becker's 14th Annual Meeting in April to discuss how they're positioning themselves to handle the complexities of Alzheimer's care. This report features key takeaways from the session.
Key learnings points:
- Top obstacles in early detection
- The approaches systems are taking to improve detection & diagnosis
- How multidisciplinary teams and digitizing processes can enhance care coordination
Please fill out the form to download the whitepaper.